Therapeutic antibodies with enhanced resistance to the evolution of SARS-CoV-2 can be identified via deep mutational learning by screening a combinatorial library of receptor-binding domains for antibody binding and escape.
- Lester Frei
- Beichen Gao
- Sai T. Reddy